Filing Flows › Comparisons › PTCT vs ACAD
PTC Therapeutics vs Acadia Pharmaceuticals: PTCT and ACAD compared
PTC Therapeutics is the larger company: $358M of revenue in its latest quarter (Q3 2026) against $342M for Acadia Pharmaceuticals (Q3 2026). PTC Therapeutics is growing faster (+70% against +23% a year earlier). Acadia Pharmaceuticals is more profitable, with an operating margin of 21.0% against 7.0%.
Where the money goes: PTCT and ACAD
PTC Therapeutics (PTCT) · Q3 2026
PTC Therapeutics, Q3 2026: revenue $358M (+70% year over year), operating margin 7.0%, net loss $51.7M, operating cash flow −$25.3M. The chart follows the revenue to costs, profit and cash.
Acadia Pharmaceuticals (ACAD) · Q3 2026
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
| PTC Therapeutics (PTCT) | Acadia Pharmaceuticals (ACAD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $358M | $342M |
| Revenue growth, Y/Y | +70% | +23% |
| Operating margin | 7.0% | 21.0% |
| Net earnings | −$51.7M | $53.5M |
| Net margin | -14.4% | 15.6% |
| Operating cash flow | −$25.3M | $11.5M |
| Free cash flow | — | $10.3M |
| Market value | $5.5B | $3.7B |
| P/E | — | 10.3× |
| Analysts’ mean target | $100.47 | $30.68 |
Where the revenue comes from
PTC Therapeutics
- Net product revenue: $276M (77%)
- Royalty revenue: $81.7M (23%)
- Collaboration and license revenue: $229K (0%)
Acadia Pharmaceuticals
- Nuplazid: $202M (59%)
- Daybue: $140M (41%)
Questions
Which is bigger, PTC Therapeutics or Acadia Pharmaceuticals?
PTC Therapeutics is the larger company: $358M of revenue in its latest quarter (Q3 2026) against $342M for Acadia Pharmaceuticals (Q3 2026).
Is PTC Therapeutics or Acadia Pharmaceuticals growing faster?
PTC Therapeutics is growing faster (+70% against +23% a year earlier).
Which is more profitable, PTC Therapeutics or Acadia Pharmaceuticals?
Acadia Pharmaceuticals is more profitable, with an operating margin of 21.0% against 7.0%.
More: PTC Therapeutics earnings · how PTC Therapeutics makes money · Acadia Pharmaceuticals earnings · how Acadia Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.